[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100479802":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":35,"locations":44,"responsibleParty":58,"collaborators":26,"id":61,"slug":26,"hasResults":62,"nctId":63,"briefTitle":64,"officialTitle":65,"acronym":66,"eligibilityCriteria":67,"healthyVolunteers":62,"sex":68,"minAge":69,"maxAge":26,"enrollmentInfo":70,"targetDuration":26,"studyType":73,"phases":74,"briefSummary":76,"conditions":77,"keywords":26,"overallStatus":46,"whyStopped":26,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"Samsung Medical Center","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Culprit-lesion only PCI arm","ACTIVE_COMPARATOR","Patients will receive culprit-lesion only PCI.",[13],"Procedure: Culprit lesion only PCI",{"label":15,"type":16,"description":17,"interventionNames":18},"Immediate multi-vesesl PCI arm","EXPERIMENTAL","Patients will receive immediate multi-vessel PCI.",[19],"Procedure: Immediate multi-vessel PCI",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"PROCEDURE","Culprit lesion only PCI","Randomization will be done after coronary angiography before or during primary PCI for IRA. Patients will be randomized to either immediate multi-vesesl PCI group or culprit-lesion only PCI group with 1:1 ratio.\n\nThis group will be taken culprit-lesion only PCI during primary PCI.",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Immediate multi-vessel PCI","Randomization will be done after coronary angiography before or during primary PCI for IRA. Patients will be randomized to either immediate multi-vesesl PCI group or culprit-lesion only PCI group with 1:1 ratio.\n\nThis group will be taken immediate multi-vesesl PCI during primary PCI.",[15],[32],{"name":33,"affiliation":5,"role":34},"Jeong Hoon Yang, MD","PRINCIPAL_INVESTIGATOR",[36,40],{"name":33,"role":37,"phone":38,"phoneExt":26,"email":39},"CONTACT","82-2-3410-3419","jhysmc@gmail.com",{"name":41,"role":37,"phone":42,"phoneExt":26,"email":43},"Ki Hong Choi, MD","82-2-3410-6653","cardiokh@gmail.com",[45],{"facility":5,"status":46,"city":47,"state":26,"zip":48,"country":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"RECRUITING","Seoul","06351","South Korea",{"type":51,"coordinates":52},"Point",[53,54],126.9784,37.566,{"lat":54,"lon":53},[57],{"name":33,"role":37,"phone":38,"phoneExt":26,"email":39},{"type":34,"investigatorFullName":59,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"Jeong Hoon Yang","Professor","100479802",false,"NCT05527717","Revascularization Strategy of Multivessel Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Veno-arterial Extracorporeal Membrane Oxygenator","REvaSCUlarization StratEgy of Multivessel Coronary Artery Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogenic SHOCK Undergoing Veno-arterial Extracorporeal Membrane Oxygenator: Randomized-Controlled Trial (RESCUE-SHOCK)","RESCUE-SHOCK","Inclusion Criteria:\n\n* Subject must be at least 19 years of age\n* Patients presented with AMI (ST-segment elevation MI \\[STEMI\\] or non-ST-segment elevation MI \\[NSTEMI\\]) complicated by CS (SCAI Shock classification C, D or E) who requiring VA-ECMO.\n* Target lesions amenable for planned primary PCI by operators' decision\n* Patients with multi-vessel disease\n\nExclusion Criteria:\n\n* Other causes of shock (hypovolemia, sepsis, obstructive shock).\n* Shock due to mechanical complication to MI (rupture of papillary muscle, the ventricular septum, or free wall).\n* Unwitnessed out of hospital cardiac arrest with persistent Glasgow coma scale \\\u003C8 after the return of spontaneous circulation.\n* Patients with single-vessel disease (Patients with single-vessel disease will be enrolled in the RESCUE-SHOCK registry)\n* Onset of shock \\>24 hours.\n* Known heparin intolerance.\n* Other severe concomitant disease with limited life expectancy \\\u003C 6 months\n* Pregnancy or breast feeding\n* Do not resuscitate wish","ALL","19 Years",{"count":71,"type":72},560,"ESTIMATED","INTERVENTIONAL",[75],"PHASE4","This study is a prospective, open-label, two-arm, randomized multicenter trial to identify whether immediate multi-vessel PCI would be better in clinical outcomes compared with culprit lesion-only PCI for AMI and multi-vessel disease with an advanced form of CS patients who require veno-arterial extracorporeal membrane oxygenator (VA-ECMO).",[78,79,80,81],"Cardiogenic Shock","Acute Myocardial Infarction","Multi Vessel Coronary Artery Disease","Extracorporeal Membrane Oxygenation","2024-11-04",{"date":84,"type":85},"2024-11-06","ACTUAL",{"date":87,"type":85},"2022-11-16",{"date":89,"type":72},"2028-12-31",{"name":5,"class":6},1]